News Articles on {?keyword?} | ABS-CBN News

ABS-CBN News
  • facebook
  • twitter
  • youtube
  • login
  • Home
  • News
  • Business
  • Entertainment
  • Life
  • Sports
  • Overseas
  • Spotlight
  • Weather
  • TV Patrol
  • TELERADYO
  • TFC
  • ANC
  • ANCX

Topic: antibody

COVID may mutate after antibody treatment: study

COVID may mutate after antibody treatment: study

Nancy Lapid, Reuters
Posted at Mar 14 10:44 AM

COVID-19 patients who receive one of the few antibody treatments that works against the Omicron variant must be carefully monitored because after the drug is infused, the virus may mutate and become resistant to it, researchers warned after seeing such cases with Delta variant patients. Read more »

 Some antibody drugs for COVID-19 may not be effective on Omicron

Some antibody drugs for COVID-19 may not be effective on Omicron

Kyodo News
Posted at Jan 27 04:18 PM

Some antibody medicines including Ronapreve may not be effective against the highly-mutated Omicron variant of the coronavirus, according to researchers at Japanese and US institutes. Read more »

Pinay nurse helps Covid patients through monoclonal antibody infusion treatment

Pinay nurse helps Covid patients through monoclonal antibody infusion treatment

Steve Angeles | TFC News Chula Vista, California
Updated as of Jan 13 02:23 PM

As Covid-19 cases rise in the US, a Filipino nurse in California makes it her mission to save patients through monoclonal antibody infusion treatment. Read more »

Experimental Lilly drug neutralizes omicron in lab

Experimental Lilly drug neutralizes omicron in lab

Nancy Lapid, Reuters
Posted at Jan 11 09:12 AM

An experimental monoclonal antibody treatment from Eli Lilly & Co is effective against all known variants of the coronavirus, including Omicron, researchers have found. Read more »

China OKs emergency approval for its first COVID drug

China OKs emergency approval for its first COVID drug

Agence France-Presse
Posted at Dec 10 09:05 AM

The move came as regulators around the world give the green light to treatments amid worries over the new omicron variant. Read more »

mRNA COVID-19 vaccines provide biggest booster impact: UK study

mRNA COVID-19 vaccines provide biggest booster impact: UK study

Alistair Smout, Reuters
Posted at Dec 03 10:22 AM

COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a British study published on Thursday has found. Read more »

GSK says tests indicate antibody drug works vs Omicron

GSK says tests indicate antibody drug works vs Omicron

Ludwig Burger, Reuters
Posted at Dec 03 04:17 AM

A study on hamsters have demonstrated sotrovimab works against viruses bio-engineered to carry a number of hallmark mutations of the Omicron variant. Read more »

Regeneron says COVID antibody treatment may be less effective vs Omicron

Regeneron says COVID antibody treatment may be less effective vs Omicron

Agence France-Presse
Posted at Dec 01 12:32 PM

US biotech firm Regeneron said its synthetic antibody treatment for COVID-19 may be less effective against Omicron, and it plans to conduct tests to determine by how much. Read more »

AstraZeneca COVID-19 drug offers 83% protection over 6 months

AstraZeneca COVID-19 drug offers 83% protection over 6 months

Pushkala Aripaka, Reuters
Posted at Nov 18 06:10 PM

AstraZeneca says its COVID-19 antibody drug cocktail offered 83% protection over six months. Read more »

US obtains COVID-19 antibody drug doses worth $1 bln

US obtains COVID-19 antibody drug doses worth $1 bln

Reuters
Posted at Nov 17 04:46 PM

US has signed contracts worth roughly $1 billion to secure the antibody-based COVID-19 treatment sotrovimab from GSK and Vir Biotechnology. Read more »

AstraZeneca's COVID antibody cocktail clears first step for registration in Australia

AstraZeneca's COVID antibody cocktail clears first step for registration in Australia

Reuters
Posted at Nov 09 03:19 PM

AstraZeneca's antibody cocktail against COVID-19 received its first nod for registration in Australia, the country's medical regulatory body said on Tuesday. Read more »

EU starts review of AstraZeneca COVID antibody cocktail

EU starts review of AstraZeneca COVID antibody cocktail

Reuters
Posted at Oct 14 10:17 PM

Europe's drug regulator said on Thursday it had started a real-time review of AstraZeneca's antibody-based COVID-19 therapy. Read more »

AstraZeneca drug cocktail effective in treating COVID: study

AstraZeneca drug cocktail effective in treating COVID: study

Reuters
Posted at Oct 11 05:12 PM

AstraZeneca's experimental COVID-19 drug cocktail succeeded in reducing severe disease or death in non-hospitalized patients in a late-stage study. Read more »

Ano ang Ronapreve na nabigyan na ng EUA ng FDA?

Ano ang Ronapreve na nabigyan na ng EUA ng FDA?

ABS-CBN News
Posted at Oct 08 08:15 AM

Ano nga ba ang Ronapreve, na nabigyan na ng EUA bilang gamot sa COVID-19? Read more »

AstraZeneca's antibody therapy prevents COVID-19, study shows

AstraZeneca's antibody therapy prevents COVID-19, study shows

Ludwig Burger, Reuters
Updated as of Aug 20 09:10 PM

AstraZeneca's new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial. Read more »

Debate over tests, jabs hobbles Hong Kong-Singapore travel bubble talks

Debate over tests, jabs hobbles Hong Kong-Singapore travel bubble talks

Denise Tsang and Dewey Sim, South China Morning Post
Posted at Jul 14 01:12 PM

Negotiations between Hong Kong and Singapore over their much-delayed travel bubble are being hobbled by disagreements over antibody tests and vaccination rules against COVID-19. Read more »

Antibody tests may lead to laxness on health protocols, experts warn

Antibody tests may lead to laxness on health protocols, experts warn

ABS-CBN News
Posted at Jul 11 04:48 PM

Experts warn that antibody testing after vaccination may lead people to become lax on health protocols. Read more »

Poor sleep history linked with more severe COVID-19

Poor sleep history linked with more severe COVID-19

Nancy Lapid, Reuters
Posted at Jun 22 07:07 AM

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Read more »

Regeneron's antibody therapy cuts deaths among some hospitalized COVID-19 patients - study

Regeneron's antibody therapy cuts deaths among some hospitalized COVID-19 patients - study

Alistair Smout, Reuters
Posted at Jun 16 08:42 PM

LONDON - A COVID-19 antibody cocktail developed by Regeneron Pharmaceuticals Inc and Roche reduced deaths in hospitalized patients whose own immune systems had failed to produce a response, a large British study found on Wednesday. Read more »

US FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

US FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

Reuters
Posted at May 27 06:23 AM

The EUA was for the treatment of mild-to-moderate COVID-19 in people aged 12 years and older, the US health regulator says. Read more »

1234 > Last
  • LATEST NEWS
  • MOST READ
  • Manila COVID-19 field hospital admits patients

  • Matagumpay na Dream Again UK Tour ni Lea Salonga, nagbigay pugay sa frontliners

  • Sperm whale natagpuang patay sa may Sarangani

  • Youth reminded to register for brgy, SK polls

  • P272 million worth of suspected shabu seized in QC

  • Lindsay Lohan announces she’s now married

  • 'Vetoed Bulacan airport ecozone bill shows independence of gov't branches'

  • Turismo sa Southern Leyte, balik sigla matapos ang 'Odette'

  • Jewelry shop, biktima ng ‘salisi gang’ sa Naga City

  • Saudi Arabia opens hajj to non-residents

  • Mga abo ni John Laylo, iuuwi muna sa kanilang tirahan

  • House lawmaker refiles absolute divorce bill

  • Long way to go but coach proud of Filipinas' progress

  • Ramos, Yumul excited for future after first stint with Gilas U16

  • OFW distributes painted bayong bags in Dubai

© 2022 ABS-CBN Corporation. All Rights Reserved.

AboutCareersPrivacyTermsContact UsAdvertise With Us